WallStSmart
XCUR

Exicure Inc

NASDAQ: XCUR · HEALTHCARE · BIOTECHNOLOGY

$3.31
-4.61% today

Updated 2026-04-29

Market cap
$22.12M
P/E ratio
P/S ratio
13.61x
EPS (TTM)
$-0.79
Dividend yield
52W range
$3 – $12
Volume
0.0M

Exicure Inc (XCUR) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$2.39M$1.04M$9.72M$118000.00$1.30M$16.61M$-483000.00$28.83M$0.00$500000.00$0.00
Revenue growth (YoY)-56.6%+838.1%-98.8%+998.3%+1181.9%-102.9%+6068.1%-100.0%-100.0%
Cost of revenue$10.12M$13.66M$13.08M$14.12M$14.12M$32.09M$1.78M$1.86M$1.42M$824000.00$460000.00
Gross profit$-7.74M$-12.62M$-3.36M$118000.00$1.30M$-15.48M$-483000.00$26.97M$-1.42M$500000.00$-460000.00
Gross margin-324.0%-1218.4%-34.6%100.0%100.0%-93.2%100.0%93.6%100.0%
R&D$10.12M$13.66M$13.08M$14.12M$19.34M$32.09M$48.98M$19.77M$1.42M$0.00$3.29M
SG&A$5.41M$3.54M$7.05M$7.82M$8.57M$9.96M$13.09M$10.89M$12.65M$5.45M$6.83M
Operating income$-13.14M$-16.16M$-10.41M$-21.82M$-26.62M$-25.44M$-62.55M$-1.83M$-15.00M$-12.23M$-10.12M
Operating margin-550.4%-1560.0%-107.1%-18490.7%-2053.8%-153.1%12950.1%-6.4%-2446.4%
EBITDA$-13.02M$-16.04M$-9.98M$-21.71M$-24.79M$-22.65M$-60.63M$78000.00$-15.54M$-8.85M$-9.66M
EBITDA margin-545.1%-1548.0%-102.7%-18394.9%-1913.0%-136.3%12553.2%0.3%-1770.2%
EBIT$-13.15M$-16.22M$-10.22M$-22.06M$-25.52M$-24.09M$-62.41M$-1.78M$-16.91M$-9.68M$-10.12M
Interest expense$0.00$724000.00$795000.00$672000.00$786000.00$573000.00$1.69M$595000.00$0.00$18000.00$1000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-13.15M$-16.94M$-11.01M$-22.41M$-26.30M$-24.67M$-64.10M$-2.58M$-16.91M$-9.70M$-4.95M
Net income growth (YoY)-28.8%+35.0%-103.6%-17.4%+6.2%-159.9%+96.0%-555.1%+42.6%+49.0%
Profit margin-550.7%-1635.2%-113.3%-18994.1%-2029.6%-148.5%13271.6%-9.0%-1940.2%